JP2007508353A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007508353A5 JP2007508353A5 JP2006534713A JP2006534713A JP2007508353A5 JP 2007508353 A5 JP2007508353 A5 JP 2007508353A5 JP 2006534713 A JP2006534713 A JP 2006534713A JP 2006534713 A JP2006534713 A JP 2006534713A JP 2007508353 A5 JP2007508353 A5 JP 2007508353A5
- Authority
- JP
- Japan
- Prior art keywords
- mol
- pharmaceutical composition
- cationic liposome
- paclitaxel
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03023539.4 | 2003-10-15 | ||
| EP03023539 | 2003-10-15 | ||
| EP04000361.8 | 2004-01-09 | ||
| EP04000361 | 2004-01-09 | ||
| PCT/EP2004/011655 WO2005039533A1 (en) | 2003-10-15 | 2004-10-15 | Method of administering cationic liposomes comprising an active drug |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012159071A Division JP2012229255A (ja) | 2003-10-15 | 2012-07-17 | 活性成分を含有するカチオンリポソームの投与方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007508353A JP2007508353A (ja) | 2007-04-05 |
| JP2007508353A5 true JP2007508353A5 (enExample) | 2007-12-06 |
| JP5645340B2 JP5645340B2 (ja) | 2014-12-24 |
Family
ID=34524705
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006534713A Expired - Fee Related JP5645340B2 (ja) | 2003-10-15 | 2004-10-15 | 活性成分を含有するカチオンリポソームの投与方法 |
| JP2012159071A Pending JP2012229255A (ja) | 2003-10-15 | 2012-07-17 | 活性成分を含有するカチオンリポソームの投与方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012159071A Pending JP2012229255A (ja) | 2003-10-15 | 2012-07-17 | 活性成分を含有するカチオンリポソームの投与方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20080063699A1 (enExample) |
| EP (2) | EP1673069B1 (enExample) |
| JP (2) | JP5645340B2 (enExample) |
| AU (1) | AU2004283464B8 (enExample) |
| CA (1) | CA2542217C (enExample) |
| DK (1) | DK2286794T3 (enExample) |
| ES (1) | ES2574231T3 (enExample) |
| HU (1) | HUE028648T2 (enExample) |
| PL (1) | PL2286794T3 (enExample) |
| PT (1) | PT2286794T (enExample) |
| WO (1) | WO2005039533A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10347710B4 (de) | 2003-10-14 | 2006-03-30 | Johannes-Gutenberg-Universität Mainz | Rekombinante Impfstoffe und deren Verwendung |
| US20050255154A1 (en) | 2004-05-11 | 2005-11-17 | Lena Pereswetoff-Morath | Method and composition for treating rhinitis |
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| KR20070114753A (ko) | 2005-02-18 | 2007-12-04 | 아브락시스 바이오사이언스 인크. | 치료제의 조합 및 투여 방식, 및 조합 요법 |
| EP1896007B1 (en) | 2005-05-04 | 2014-03-19 | Medigene AG | Method of administering a cationic liposomal preparation comprising paclitexel |
| PL1919450T3 (pl) * | 2005-09-01 | 2014-11-28 | Meda Ab | Kompozycja liposomowa zawierająca lek przeciwhistaminowy i kortykosteroid oraz jej zastosowanie do wytwarzania leku do leczenia nieżytu nosa i chorób spokrewnionych |
| DE102005046490A1 (de) | 2005-09-28 | 2007-03-29 | Johannes-Gutenberg-Universität Mainz | Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen |
| KR100658436B1 (ko) * | 2005-12-09 | 2006-12-27 | 한국화학연구원 | 아데노실코발라민 함유 피부질환 치료용 외용제 조성물 |
| BRPI0709075A2 (pt) * | 2006-03-20 | 2011-10-11 | Medigene Ag | tratamento de cáncer de mama triplo receptor negativo |
| WO2007134819A1 (en) * | 2006-05-18 | 2007-11-29 | Medigene Ag | Cationic liposomal preparations for the treatment of rheumatoid arthritis |
| MX2012011155A (es) | 2010-03-29 | 2012-12-05 | Abraxis Bioscience Llc | Metodos para mejorar suministros de farmacos y efectividad de agentes terapeuticos. |
| EP3141245A1 (en) | 2010-03-29 | 2017-03-15 | Abraxis BioScience, LLC | Methods of treating cancer |
| EP2394640A1 (en) | 2010-05-21 | 2011-12-14 | MediGene AG | Improved liposomal formulations of lipophilic compounds |
| MX347225B (es) | 2010-06-04 | 2017-04-19 | Abraxis Bioscience Llc * | Metodos de tratamiento contra el cancer pancreatico. |
| US20120028335A1 (en) | 2010-07-28 | 2012-02-02 | Life Technologies Corporation | Anti-viral azide-containing compounds |
| US9144575B2 (en) | 2010-07-28 | 2015-09-29 | Life Technologies Corporation | Anti-viral azide containing compounds |
| JP6112512B2 (ja) * | 2010-12-01 | 2017-04-12 | レクシ ファーマ インコーポレイテッド | 難治性癌を治療するための方法 |
| PL3892295T3 (pl) | 2011-05-24 | 2023-07-24 | BioNTech SE | Zindywidualizowane szczepionki przeciwnowotworowe |
| AU2013212068B2 (en) | 2012-01-26 | 2018-02-15 | Life Technologies Corporation | Methods for increasing the infectivity of viruses |
| WO2013143555A1 (en) | 2012-03-26 | 2013-10-03 | Biontech Ag | Rna formulation for immunotherapy |
| EP3417874B1 (en) | 2012-11-28 | 2024-09-11 | BioNTech SE | Individualized vaccines for cancer |
| DE102013009744A1 (de) * | 2013-03-26 | 2014-10-02 | Forschungszentrum Jülich GmbH | Fusionsmischung zur lipidhaltigen Membranmodifikation einer beliebigen Lipidmembran, einer Zellmembran, einem Bestandteil einer Zellmembran oder einer von den übrigen Zell- Bestandteilen getrennten Zellmembran in vivo oder in vitro |
| WO2014180490A1 (en) | 2013-05-10 | 2014-11-13 | Biontech Ag | Predicting immunogenicity of t cell epitopes |
| WO2016045732A1 (en) | 2014-09-25 | 2016-03-31 | Biontech Rna Pharmaceuticals Gmbh | Stable formulations of lipids and liposomes |
| WO2016128060A1 (en) | 2015-02-12 | 2016-08-18 | Biontech Ag | Predicting t cell epitopes useful for vaccination |
| CA3026454C (en) | 2015-06-04 | 2023-07-04 | Crititech, Inc. | Collection device and methods for use |
| ES3055492T3 (en) | 2015-09-16 | 2026-02-12 | Dfb Soria Llc | Delivery of drug nanoparticles and methods of use thereof |
| WO2017059902A1 (en) | 2015-10-07 | 2017-04-13 | Biontech Rna Pharmaceuticals Gmbh | 3' utr sequences for stabilization of rna |
| EP3854381A1 (en) | 2016-04-04 | 2021-07-28 | Crititech, Inc. | Methods for solid tumor treatment |
| CA3043620A1 (en) * | 2016-11-11 | 2018-05-17 | Western University Of Health Sciences | Methods of treating upper tract urothelial carcinomas |
| TWI852903B (zh) * | 2017-01-05 | 2024-08-21 | 杏國新藥股份有限公司 | 胰臟癌治療 |
| WO2018170196A1 (en) | 2017-03-15 | 2018-09-20 | Dfb Soria, Llc | Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes |
| WO2018224166A1 (en) | 2017-06-09 | 2018-12-13 | Biontech Rna Pharmaceuticals Gmbh | Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy |
| CA3063420A1 (en) | 2017-06-09 | 2018-12-13 | Crititech, Inc. | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
| WO2018231908A1 (en) | 2017-06-14 | 2018-12-20 | Crititech, Inc. | Methods for treating lung disorders |
| KR20250057947A (ko) | 2017-10-03 | 2025-04-29 | 크리티테크, 인크. | 암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달 |
| EP3765035A4 (en) | 2018-03-16 | 2021-10-27 | DFB Soria, LLC | TOPICAL THERAPY FOR THE TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) AND COLD CANCER USING TAXANE NANOPARTICLES |
| WO2024160190A1 (zh) * | 2023-01-31 | 2024-08-08 | 石药集团中奇制药技术（石家庄）有限公司 | 紫杉醇阳离子脂质体治疗肿瘤的用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1254135B (it) | 1992-01-16 | 1995-09-08 | Sigma Tau Ind Farmaceuti | Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antibatterica. |
| ATE194767T1 (de) * | 1992-03-23 | 2000-08-15 | Univ Georgetown | In liposomen verkapseltes taxol und verwendungsverfahren |
| DE4430593C2 (de) * | 1994-08-20 | 1999-01-14 | Max Delbrueck Centrum | Verfahren zur Herstellung von Liposomal verkapseltem Taxol |
| US5837283A (en) * | 1997-03-12 | 1998-11-17 | The Regents Of The University Of California | Cationic lipid compositions targeting angiogenic endothelial cells |
| US7112338B2 (en) * | 1997-03-12 | 2006-09-26 | The Regents Of The University Of California | Cationic liposome delivery of taxanes to angiogenic blood vessels |
| US6146659A (en) * | 1998-07-01 | 2000-11-14 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
| US7314637B1 (en) * | 1999-06-29 | 2008-01-01 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
| KR100591767B1 (ko) * | 1999-09-09 | 2006-06-23 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 탁산의 맥관형성 혈관 전달을 위한 양이온성 리포좀 |
| UY27185A1 (es) * | 2001-02-28 | 2002-09-30 | Bristol Myers Squibb Co | Dosificación metronómica de taxanos |
| EP1553924B1 (en) * | 2002-06-26 | 2010-12-08 | MediGene AG | Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| EP1530465B2 (en) * | 2002-06-26 | 2015-12-16 | MediGene AG | Method of producing a cationic liposomal preparation comprising a lipophilic compound |
-
2004
- 2004-10-15 WO PCT/EP2004/011655 patent/WO2005039533A1/en not_active Ceased
- 2004-10-15 PL PL10180750.1T patent/PL2286794T3/pl unknown
- 2004-10-15 DK DK10180750.1T patent/DK2286794T3/en active
- 2004-10-15 EP EP04790494.1A patent/EP1673069B1/en not_active Expired - Lifetime
- 2004-10-15 HU HUE10180750A patent/HUE028648T2/en unknown
- 2004-10-15 ES ES10180750.1T patent/ES2574231T3/es not_active Expired - Lifetime
- 2004-10-15 JP JP2006534713A patent/JP5645340B2/ja not_active Expired - Fee Related
- 2004-10-15 PT PT101807501T patent/PT2286794T/pt unknown
- 2004-10-15 US US10/575,779 patent/US20080063699A1/en not_active Abandoned
- 2004-10-15 CA CA2542217A patent/CA2542217C/en not_active Expired - Lifetime
- 2004-10-15 EP EP10180750.1A patent/EP2286794B8/en not_active Expired - Lifetime
- 2004-10-15 AU AU2004283464A patent/AU2004283464B8/en not_active Ceased
-
2012
- 2012-07-17 JP JP2012159071A patent/JP2012229255A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007508353A5 (enExample) | ||
| JP4729503B2 (ja) | 抗癌剤の奏効率増強剤 | |
| JP5704788B2 (ja) | 癌の治療および過剰増殖性疾患の治療のための、免疫遺伝子療法と化学療法の組み合わせ | |
| JP2018528184A5 (enExample) | ||
| CN115487187B (zh) | 一种用于治疗胃癌的喹啉衍生物 | |
| JP6855488B2 (ja) | 食道癌を治療するためのキノリン誘導体の使用とその治療方法、医薬組成物及びキット | |
| TWI522105B (zh) | 偏亞砷酸鈉於治療癌疼痛及炎症之用途 | |
| JP2003528920A (ja) | 血管損傷性活性を有する併用療法 | |
| JP2010043115A (ja) | 腫瘍転移および癌の治療における５−フルオロウラシルの有効性の増強 | |
| JP2023546362A5 (enExample) | ||
| CN101687104A (zh) | 包括长春氟宁和曲妥单抗的癌症治疗联合疗法 | |
| JP2009536956A (ja) | 抗癌治療法 | |
| JP2008540364A5 (enExample) | ||
| CN102438608A (zh) | 包含ave8062和索拉非尼的抗肿瘤组合 | |
| O'Shaughnessy et al. | Current status of paclitaxel in the treatment of breast cancer | |
| CN101652138A (zh) | 1-取代芳基-2（1h）-吡啶酮化合物的新医药用途 | |
| Tralongo et al. | Chemotherapy in frail elderly patients with hormone-refractory prostate cancer: A “real world” experience | |
| JP2006523664A5 (enExample) | ||
| CN104968340A (zh) | 治疗肝脏疾病或病状的用途和方法 | |
| Kuo et al. | Functionalized drug-gene delivery materials to transport inhibitor of apoptosis protein antagonists for tumor malignancy management | |
| CN113993515B (zh) | 使用藏红花酸治疗实体肿瘤的方法 | |
| EP2826482A1 (en) | Novel antitumor agent comprising combination of three agents | |
| KR20140022856A (ko) | 치료적 요법 | |
| KR20160009677A (ko) | 암 치료를 위한 ro5503781, 카페시타빈과 옥살리플라틴의 조합 | |
| KR20060036058A (ko) | 결장직장암의 치료를 위한 혈관 손상 활성을 갖는 5ｆｕ,ｃｐｔ-11 또는 5-ｆｕ 및 ｃｐｔ-11과 함께 ｚｄ6126을포함하는 조성물 |